Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
6.5
37.96%
60%
—
279.74%
Every year
—
5 Years
Score6.5
Net Growth37.96%
Net Trend60%
Net Income Consistency—
Rev Growth279.74%
Rev TrendEvery year
Revenue Consistency—
Castle Biosciences Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 62M to $ 344M and net income went from -$ 10M to -$ 24M. Revenue increased in every one of those 5 years; net income in 3.
Castle Biosciences Inc currently holds a 5-year HDB Score of 6.5 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 31.43 | — |
1 Year2025-08-12 | $ 19.34 | 62.51% |
5 Years2021-08-12 | $ 66.65 | -52.84% |
All Time2019-07-25 | $ 21.40 | 46.87% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2019-07-25 |
|---|---|---|---|---|
| Price | $ 31.43 | $ 19.34 | $ 66.65 | $ 21.40 |
| Return | — | 62.51% | -52.84% | 46.87% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 357M | -$ 19M | $ 266M |
| 2025 | $ 344M | -$ 24M | $ 299M |
| 2024 | $ 332M | $ 18M | $ 293M |
| 2023 | $ 219M | -$ 57M | $ 243M |
| 2022 | $ 137M | -$ 67M | $ 258M |
| 2021 | $ 94M | -$ 31M | $ 329M |
| 2020 | $ 62M | -$ 10M | $ 409M |
| IPO2019 | $ 51M | $ 5M | $ 98M |
Explore beyond CSTL
You're looking at Castle Biosciences Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
